POSTER: Investigating the Potential for a Canadian Accelerated Pathway for Health Canada Priority Review Drugs

April 22, 2026

Research Objectives:

This study aims to investigate the potential for a Canadian accelerated pathway for all Priority Review files by determining the number of files this would apply to in a given year and their characteristics (phase 1) and the potential impact on time to listing (phase 2), with the objective of understanding the potential to establish a more timely and equitable access framework for Canadian patients. This poster presents findings from phase 1 of the research.

Poster presented at the 2026 CDA-AMC Symposium, Ottawa, Canada, April 22, 2026.


Next
Next

A Story That Lives On